Aptamers are a small segment of oligonucleotides screened in vitro and can be highly affinity and strong with the corresponding ligands.
The combination of the opposite sex, its appearance provides a new research platform for high efficiency and fast recognition for the chemical and biomedical circles, and has shown good prospects in many aspects.
Nucleic acid aptamers are highly specific and highly selective in combination with a variety of target substances and are therefore widely used in the field of biosensors. When a nucleic acid aptamer specifically binds to a target substance, the configuration of the nucleic acid aptamer itself changes. Researchers have applied nucleic acid aptamers to probes and developed many electrochemical sensors based on the configuration changes of nucleic acid aptamers, also known as E-AB (Electrochemical aptamer-based) sensors, combined with electrochemical detection methods. The E-AB sensor improves the application of nucleic acid aptamers in the sensor field because of its portability, simple operation and low cost.

The global Aptamer market was valued at 32 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 15.5% during 2019-2025.
This report focuses on Aptamer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aptamer market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Aptamer in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Aptamer manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers

Segment by Application
Research and Development
Drug Discovery